Form 8-K - Current report:
SEC Accession No. 0001193125-24-197943
Filing Date
2024-08-09
Accepted
2024-08-09 17:06:30
Documents
17
Period of Report
2024-08-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d723355d8k.htm   iXBRL 8-K 28296
2 EX-1.1 d723355dex11.htm EX-1.1 235360
3 EX-5.1 d723355dex51.htm EX-5.1 11840
7 GRAPHIC g723355g0809104457943.jpg GRAPHIC 2357
8 GRAPHIC g723355g0809104458147.jpg GRAPHIC 1790
  Complete submission text file 0001193125-24-197943.txt   474403

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240808.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240808_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240808_pre.xml EX-101.PRE 11255
19 EXTRACTED XBRL INSTANCE DOCUMENT d723355d8k_htm.xml XML 3650
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 241193893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)